FFO
IART icon

Fortitude Family Office’s Integra LifeSciences IART Stock Holding History

Fortitude Family Office’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18 Buy
+1
New +$14 ﹤0.01% 2243

Other funds holding IART

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Fortitude Family Office's IART Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Integra LifeSciences (IART) in Q2 2026: 1 share worth $18. The stake represents ﹤0.01% of the portfolio and ranks #2243 among its holdings.

33 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Fortitude Family Office held 1 share of Integra LifeSciences worth $18 as of Q2 2026.
  • Integra LifeSciences was a new Fortitude Family Office position in Q2 2026.
  • Integra LifeSciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2243 holding.
  • 33 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.